Guangzhou, China

Shaoyun Lin

This inventor holds 2 USPTO granted patents. Top assignee: Lumiere Therapeutics Co., Ltd.. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shaoyun Lin. Retrieved from https://idiyas.com/inventor/shaoyun-lin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.7

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Shaoyun Lin

Introduction

Shaoyun Lin is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of genetic engineering, particularly through his innovative work on adenosine deaminases and base editors. His research has the potential to revolutionize genetic editing techniques.

Latest Patents

Shaoyun Lin holds a patent for "Engineered adenosine deaminases and base editors thereof." This patent discloses adenosine deaminases and base editors that comprise these enzymes. The technology demonstrated superior adenine editing effects, achieving a transformation from A·T base pairs to G·C base pairs at the DNA level.

Career Highlights

Lin's career is marked by his dedication to advancing genetic engineering. His work at Lumiere Therapeutics Co., Ltd. has positioned him as a key player in the development of innovative genetic editing tools. His research has garnered attention for its potential applications in various fields, including medicine and biotechnology.

Collaborations

Some of his notable coworkers include Bohong Chen and Yang Hu. Their collaborative efforts contribute to the ongoing advancements in the field of genetic engineering.

Conclusion

Shaoyun Lin's contributions to genetic engineering through his patented innovations highlight his role as a leading inventor in this field. His work continues to pave the way for future advancements in genetic editing technologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…